(Q33375264)

26 July 2017

title

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

Chow KV

1

1 reference

26 July 2017

Carroll R

2

1 reference

26 July 2017

Branley P

3

1 reference

26 July 2017

Nicholls K

4

1 reference

26 July 2017

Becker G

5

1 reference

26 July 2017

Hogan C

6

1 reference

26 July 2017

publication date

1 May 2007

1 reference

Internal Medicine Journal

26 July 2017

published in

1 reference

26 July 2017

volume

37

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

329-332

1 reference

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01338.X

10.1111/J.1445-5994.2007.01338.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference